Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Gossamer Bio stock | $12.75

Learn how to easily invest in Gossamer Bio stock.

Gossamer Bio Inc is a biotechnology business based in the US. Gossamer Bio shares (GOSS) are listed on the NASDAQ and all prices are listed in US Dollars. Gossamer Bio employs 195 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Gossamer Bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GOSS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Gossamer Bio stock price (NASDAQ: GOSS)

Use our graph to track the performance of GOSS stocks over time.

Gossamer Bio shares at a glance

Information last updated 2021-10-23.
Latest market close$12.75
52-week range$7.04 - $14.30
50-day moving average $11.98
200-day moving average $9.39
Wall St. target price$19.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.26

Buy Gossamer Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Gossamer Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Gossamer Bio price performance over time

Historical closes compared with the close of $12.75 from 2021-10-26

1 week (2021-10-20) 0.24%
1 month (2021-09-27) -1.32%
3 months (2021-07-27) 67.98%
6 months (2021-04-27) 46.55%
1 year (2020-10-27) 33.79%
2 years (2019-10-25) -31.67%
3 years (2018-10-23) N/A
5 years (2016-10-23) N/A

Gossamer Bio financials

Gross profit TTM $0
Return on assets TTM -25.63%
Return on equity TTM -74.85%
Profit margin 0%
Book value $3.09
Market capitalisation $967.4 million

TTM: trailing 12 months

Shorting Gossamer Bio shares

There are currently 9.3 million Gossamer Bio shares held short by investors – that's known as Gossamer Bio's "short interest". This figure is 4.1% down from 9.7 million last month.

There are a few different ways that this level of interest in shorting Gossamer Bio shares can be evaluated.

Gossamer Bio's "short interest ratio" (SIR)

Gossamer Bio's "short interest ratio" (SIR) is the quantity of Gossamer Bio shares currently shorted divided by the average quantity of Gossamer Bio shares traded daily (recently around 606818.14014407). Gossamer Bio's SIR currently stands at 15.27. In other words for every 100,000 Gossamer Bio shares traded daily on the market, roughly 15270 shares are currently held short.

However Gossamer Bio's short interest can also be evaluated against the total number of Gossamer Bio shares, or, against the total number of tradable Gossamer Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Gossamer Bio's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Gossamer Bio shares in existence, roughly 120 shares are currently held short) or 0.1452% of the tradable shares (for every 100,000 tradable Gossamer Bio shares, roughly 145 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Gossamer Bio.

Find out more about how you can short Gossamer Bio stock.

Gossamer Bio share dividends

We're not expecting Gossamer Bio to pay a dividend over the next 12 months.

Gossamer Bio share price volatility

Over the last 12 months, Gossamer Bio's shares have ranged in value from as little as $7.04 up to $14.3. A popular way to gauge a stock's volatility is its "beta".

GOSS.US volatility(beta: 0.98)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Gossamer Bio's is 0.9831. This would suggest that Gossamer Bio's shares are less volatile than average (for this exchange).

Gossamer Bio overview

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2, which is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma; in Phase II clinical trial to treat patients with chronic rhinosinusitis with and without nasal polyps; and in Phase 2 clinical trial in patients with chronic spontaneous urticarial. The company is also developing GB002, an orally inhaled, small molecule, platelet-derived growth factor receptor kinase inhibitor in Phase Ib clinical trial for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule in Phase Ib clinical trial for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; and GB1275, an oral, small molecule, CD11b modulator in Phase 1/2 clinical trial for the treatment of selected solid tumor types. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds.

Gossamer Bio in the news

There are no recent company news

Frequently asked questions

What percentage of Gossamer Bio is owned by insiders or institutions?
Currently 11.661% of Gossamer Bio shares are held by insiders and 82.176% by institutions.
How many people work for Gossamer Bio?
Latest data suggests 195 work at Gossamer Bio.
When does the fiscal year end for Gossamer Bio?
Gossamer Bio's fiscal year ends in December.
Where is Gossamer Bio based?
Gossamer Bio's address is: 3013 Science Park Road, San Diego, CA, United States, 92121
What is Gossamer Bio's ISIN number?
Gossamer Bio's international securities identification number is: US38341P1021
What is Gossamer Bio's CUSIP number?
Gossamer Bio's Committee on Uniform Securities Identification Procedures number is: 38341P102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site